Misplaced Pages

Rencofilstat

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (December 2023)
Pharmaceutical compound
Rencofilstat
Clinical data
Other namesCRV431
Identifiers
IUPAC name
  • N--8-hydroxy-7-methyloctyl]acetamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC67H122N12O13
Molar mass1303.784 g·mol
3D model (JSmol)
SMILES
  • CC1C(=O)N((C(=O)N((C(=O)N(C(=O)N((C(=O)N(C(=O)N(C(=O)N((C(=O)N((C(=O)N((C(=O)N((C(=O)N1)((C)CCCCCCNC(=O)C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C
InChI
  • InChI=1S/C67H122N12O13/c1-26-48-63(88)73(19)46(17)62(87)74(20)50(34-38(4)5)59(84)72-53(41(10)11)66(91)75(21)49(33-37(2)3)58(83)69-44(15)57(82)70-45(16)61(86)76(22)51(35-39(6)7)64(89)77(23)52(36-40(8)9)65(90)78(24)54(42(12)13)67(92)79(25)55(60(85)71-48)56(81)43(14)31-29-27-28-30-32-68-47(18)80/h37-46,48-56,81H,26-36H2,1-25H3,(H,68,80)(H,69,83)(H,70,82)(H,71,85)(H,72,84)/t43-,44+,45-,46-,48+,49+,50+,51+,52+,53+,54+,55+,56-/m1/s1
  • Key:KBARHGHBFILILC-NGIJKBHDSA-N

Rencofilstat (CRV431) is a pan-cyclophilin inhibitor and analog of cyclosporine A developed for nonalcoholic steatohepatitis and hepatocellular carcinoma.

References

  1. Harrison, Stephen A.; Mayo, Patrick R.; Hobbs, Todd M.; Canizares, Carlos; Foster, Erin P.; Zhao, Caroline; Ure, Daren R.; Trepanier, Daniel J.; Greytok, Jill A.; Foster, Robert T. (December 2022). "Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single-blind, placebo-controlled study in F2/F3 NASH". Hepatology Communications. 6 (12): 3379–3392. doi:10.1002/hep4.2100. PMC 9701462. PMID 36271849.
  2. Stauffer, Winston; Bobardt, Michael; Ure, Daren; Foster, Robert; Gallay, Philippe (17 October 2023). "The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity". Viruses. 15 (10): 2099. doi:10.3390/v15102099. PMC 10612079. PMID 37896876.
  3. Remenchik, Ellen; Mayo, Patrick R.; Hobbs, Todd M.; Greytok, Jill A.; Foster, Erin P.; Zhao, Caroline; Ure, Daren; Trepanier, Daniel J.; Foster, Robert T. (March 2023). "Effect of a High-Fat Meal on Single-Dose Rencofilstat (CRV431) Oral Bioavailability in Healthy Human Subjects". Clinical Pharmacology in Drug Development. 12 (3): 287–293. doi:10.1002/cpdd.1179. PMID 36251165. S2CID 252915396.
  4. Ure, Daren; Leslie, Jack; Haddon, Lacey; Fu, Claude; Mann, Jelena; Mann, Derek (4 April 2023). "Abstract 4125: Rencofilstat exerts a dominant role in synergistic anti-PD1-combination effects in a fatty liver model of hepatocellular carcinoma". Cancer Research. 83 (7_Supplement): 4125. doi:10.1158/1538-7445.AM2023-4125. S2CID 258002007.
Categories: